- Suchergebnis für K05098
Cookie-Einstellungen
Diese Website benutzt Cookies, die für den technischen Betrieb der Website erforderlich sind und stets gesetzt werden. Andere Cookies, die den Komfort bei Benutzung dieser Website erhöhen, der Direktwerbung dienen oder die Interaktion mit anderen Websites und sozialen Netzwerken vereinfachen sollen, werden nur mit Ihrer Zustimmung gesetzt.
Konfiguration
Technisch erforderlich
Diese Cookies sind für die Grundfunktionen des Shops notwendig.
"Alle Cookies ablehnen" Cookie
"Alle Cookies annehmen" Cookie
Ausgewählter Shop
CSRF-Token
Cookie-Einstellungen
FACT-Finder Tracking
Individuelle Preise
Kundenspezifisches Caching
Session
Währungswechsel
Komfortfunktionen
Diese Cookies werden genutzt um das Einkaufserlebnis noch ansprechender zu gestalten, beispielsweise für die Wiedererkennung des Besuchers.
Facebook-Seite in der rechten Blog - Sidebar anzeigen
Merkzettel
Statistik & Tracking
Endgeräteerkennung
Kauf- und Surfverhalten mit Google Tag Manager
Partnerprogramm
Zu "K05098" wurden 356 Artikel gefunden!
Filter schließen
Filtern nach:
Für die Filterung wurden keine Ergebnisse gefunden!
NEU
Artikelnummer: Cay45474-1
VEGFR2 kinase inhibitor IV is an inhibitor of VEGFR2 (IC50 = 19 nM). It is greater than 100-fold selective for VEGFR2 over FGFR1 and Src but only 1.8-, 10-, and 10-fold selective over PDGFRbeta, FLT1, and FLT2, respectively. VEGFR2 kinase inhibitor IV inhibits mitogenesis in human umbilical vein endothelial cells...
| Schlagworte: | Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor IV,... |
| Anwendung: | VEGFR2 inhibitor |
| CAS | 216661-57-3 |
| MW: | 307.37 D |
ab 278,00 €
Artikelnummer: TGM-TMPS-00146-10ug
Description: VEGFR2/KDR Protein, Mouse, Recombinant (aa 192-761, hFc) is expressed in HEK293 Cells. The accession number is P35918.
| Schlagworte: | VEGFR , VEGFR2 , CD309 , KDR , FLK1 |
| MW: | 153.5 kD |
ab 34,00 €
Artikelnummer: ARG81425.96
Protein function: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. Promotes proliferation, survival, migration and differentiation of...
| Schlagworte: | KDR, FLK1, CD309, FLK-1, VEGFR-2, EC=2.7.10.1, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine... |
| Anwendung: | ELISA |
| Spezies-Reaktivität: | human |
1.118,00 €
Artikelnummer: LKT-S5868.25
c-Raf, Ret, VEGFR2 inhibitor, potential STAT3/5 inhibitor, potential HMT inhibitor.
| Schlagworte: | 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide |
| Anwendung: | BRAF / FLT3 / PDGFRB / VEGFR2 / VEGFR3 / c-KIT inhibitor |
| CAS | 284461-73-0 |
| MW: | 464.82 D |
ab 109,00 €
Artikelnummer: Cay43119-10
A VEGFR2 inhibitor (IC50 = 23 nM), selective for VEGFR2 over 22 other kinases (IC50s = 400->10,000 nM), inhibits VEGF-induced proliferation in HUVECs (IC50 = 25 nM), decreases tumor volume in an L2987 lung adenocarcinoma mouse xenograft model at 90 or 180 mg/kg per day
| Schlagworte: | N-cyclopropyl-2,4-difluoro-5-[[[2-(2-pyridinylamino)-5-thiazolyl]methyl]amino]-benzamide |
| Anwendung: | VEGFR2 inhibitor |
| CAS | 639858-32-5 |
| MW: | 401.44 D |
ab 122,00 €
Artikelnummer: BPS-40325
Vascular endothelial growth factor receptor 2 (VEGFR2), also called Kinase insert Domain receptor (KDR), is a tyrosine kinase (TK) receptor for VEGFs that plays a central role in tumor angiogenesis, therefore the inhibition of VEGFR2 is a promising therapeutic strategy for inhibiting angiogenesis and tumor growth....
| Schlagworte: | KDR, Kinase Insert Domain Receptor, VEGFR2, Vascular Endothelial Growth Factor Receptor 2, CD309, FLK-1, Fetal Liver... |
| Anwendung: | Enzyme kinetics, drug discovery, HTS |
| Spezies-Reaktivität: | human |
842,00 €
Artikelnummer: SYN-1215-M001
Soluble in DMSO. Potent protein kinase VEGFR2 inhibitor (2nm range). Binds to the pseudokinase domain of MLKL and blocks cell death by necroptosis, as well. With regards to its role in necroptosis, it is an ATP-mimetic that was shown to bind recombinant mouse MLKL pseudokinase domain, which showed inhibited...
| Schlagworte: | GW806742X, AC1NS7PT, AGN-PC-0LQ49Y |
| Anwendung: | VEGFR2 inhibitor |
| CAS | 579515-63-2 |
| MW: | 573,6 D |
ab 139,00 €
Artikelnummer: Cay18464-1
XL184 is an inhibitor of VEGFR2 (IC50 = 0.035 nM). It is selective for VEGFR2 over Ron, EGFR, IGF-1R, and EphA4/B4, but also inhibits c-Met, RET, c-Kit, Axl, FLT3, and Tie2 (IC50s = 1.3, 5.2, 4.6, 7, 11.3, and 14.3 nM, respectively). XL184 (4.6 nM) inhibits VEGF-induced tubule formation in human microvascular...
| Schlagworte: | BMS-907351, Cabozantinib, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide |
| Anwendung: | Pan tyrosine kinase inhibitor |
| CAS | 849217-68-1 |
| MW: | 501.5 D |
ab 69,00 €
Artikelnummer: Cay21268-5
Apatinib is a tyrosine kinase inhibitor that potently suppresses the kinase activity of vascular endothelial growth factor 2 (VEGFR2, IC50 = 1 nM). It is less effective against c-kit (IC50 = 429 nM), Ret (IC50 = 13 nM), and c-src (IC50 = 53 nM) and does not inhibit EGFR, Her-2, or FGFR1 (IC50s = >10 µM). Apatinib...
| Schlagworte: | YN968D1, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide |
| Anwendung: | VEGFR2 inhibitor |
| CAS | 811803-05-1 |
| MW: | 397.5 D |
ab 144,00 €
Artikelnummer: Cay13182-5
SU 5402 is an inhibitor of the tyrosine kinase domains of VEGFR2, FGFR1, and PDGFRbeta (IC50s = 0.02, 0.03, and 0.51 µM, respectively). It is much less effective against other receptor tyrosine kinases. SU 5402 is commonly used to evaluate the role of FGFR1 in cellular functions.Formal Name:...
| Schlagworte: | 2-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrole-3-propanoic acid |
| Anwendung: | FGFR1 /?VEGFR2 inhibitor |
| CAS | 215543-92-3 |
| MW: | 296.3 D |
ab 44,00 €
Artikelnummer: Cay42248-1
A VEGFR1, VEGFR2, and EGFR inhibitor (IC50s = 0.7, 0.03, and 0.4 µM, respectively), selective for these kinases over PDGFRbeta, FGFR1, and HER2 (IC50s = 3.4, >100, and >100 µM, respectively) and MEK, Cdk2, IGF-1R, Akt, and Tie2 (IC50s = >10, >10, >20, >20, and >100 µM, respectively), selectively inhibits VEGF- or...
| Schlagworte: | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[2-(1H-1,2,3-triazol-1-yl)ethoxy]-4-quinazolinamine |
| Anwendung: | VEGFR1/VEGFR2/EGFR inhibitor |
| CAS | 413599-62-9 |
| MW: | 459.3 D |
ab 76,00 €
Artikelnummer: Cay14617-1
DMXAA is a xanthene which acts as a tumor vascular disrupting agent, inducing apoptosis in tumor vascular endothelium resulting in necrosis at the tumor core. It potently activates the TANK-binding kinase 1-interferon regulatory factor 3 (TBK1/IRF3) signaling pathway in leukocytes, inducing type-I-interferon (IFN)...
| Schlagworte: | 5,6-Dimethylxanthenone-4-acetic Acid, ASA 404, NSC 640488, Vadimezan, 5,6-dimethyl-9-oxo-9H-xanthene-4-acetic acid |
| Anwendung: | VEGFR2 inhibitor, apoptosis inducer |
| CAS | 117570-53-3 |
| MW: | 282.3 D |
ab 55,00 €